Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MART therapy vs fixed-dose ICS/LABA in children after severe asthma exacerbation
TCTR20260326005Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of long-acting beta2-agonists + inhaled corticosteroids in asthma, sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Planned start Apr 2026; status: not yet recruiting.
02
Drugs
long-acting beta2-agonists + inhaled corticosteroids
03
Conditions
asthma
Beyond the preview
Go deeper on TCTR20260326005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260326005.